Skip to main content

Tectonic Therapeutic, Inc 8-K, filed Nov 5, 2026

Tectonic Therapeutic, Inc. (TECX)

8-K 2026-11-05 For: 2026-11-05
View Original
Added on November 05, 2026

About this 8-K

Tectonic Therapeutic, Inc filed this 8-K on November 5, 2026.

Tectonic reported favorable TX2100 results, dosed the first patient in the TX45 ALPINE trial and expects APEX topline results by the end of January 2027. Cash of $234.7 million at September 30, 2026 supports runway into Q1 2029. AI summary

Items reported

  • Item 2.01: Completed an acquisition or sale of assets
  • Item 9.01: Financial statements and exhibits